Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by Cold Genesys, Inc.
Sponsor:
Information provided by (Responsible Party):
Cold Genesys, Inc.
ClinicalTrials.gov Identifier:
NCT01438112
First received: September 19, 2011
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)